Page last updated: 2024-11-05

triamterene and alpha-L-Iduronidase Deficiency

triamterene has been researched along with alpha-L-Iduronidase Deficiency in 1 studies

Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Siddiqui, A1
Dundar, H1
Sharma, J1
Kaczmarczyk, A1
Echols, J1
Dai, Y1
Sun, CR1
Du, M1
Liu, Z1
Zhao, R1
Wood, T1
Sanders, S1
Rasmussen, L1
Bostwick, JR1
Augelli-Szafran, C1
Suto, M1
Rowe, SM1
Bedwell, DM1
Keeling, KM1

Other Studies

1 other study available for triamterene and alpha-L-Iduronidase Deficiency

ArticleYear
Triamterene Functions as an Effective Nonsense Suppression Agent for MPS I-H (Hurler Syndrome).
    International journal of molecular sciences, 2023, Feb-24, Volume: 24, Issue:5

    Topics: Animals; Codon, Nonsense; Diuretics; Glycosaminoglycans; Iduronidase; Mucopolysaccharidosis I; Triam

2023